WallStreetZenWallStreetZen

NASDAQ: TCRX
Tscan Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TCRX past revenue growth

How has TCRX's revenue growth performed historically?
Company
55.52%
Industry
148.4%
Market
16.96%
TCRX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TCRX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TCRX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TCRX earnings and revenue history

Current Revenue
$21.0M
Current Earnings
-$89.2M
Current Profit Margin
-423.9%

TCRX Return on Equity

Current Company
-60.6%
Current Industry
-63.5%
Current Market
188%
TCRX's Return on Equity (-60.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TCRX announces earnings.

TCRX Return on Assets

Current Company
-33.9%
Current Industry
2.9%
TCRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TCRX Return on Capital Employed

Current Company
-35.27%
Current Industry
19.5%
TCRX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TCRX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TCRX$21.05M-$80.10M-$89.22M+264.00%N/A
PGEN$6.23M-$89.23M-$95.90M-47.16%N/A
NKTX$0.00-$109.41M-$117.50M-100.00%N/A
AURA$0.00-$73.14M-$76.41MN/AN/A
RANI$0.00-$27.02M-$33.97M-100.00%N/A
View Top Biotech Stocks

TCRX earnings dates

Next earnings date
May 7, 2024

Tscan Therapeutics Earnings & Revenue FAQ

What were TCRX's earnings last quarter?

On Invalid Date, Tscan Therapeutics (NASDAQ: TCRX) reported Q4 2023 earnings per share (EPS) of -$0.11, up 85.71% year over year. Total Tscan Therapeutics earnings for the quarter were -$19.61 million. In the same quarter last year, Tscan Therapeutics's earnings per share (EPS) was -$0.77.

If you're new to stock investing, here's how to buy Tscan Therapeutics stock.

What was TCRX's earnings growth in the past year?

As of Q2 2024, Tscan Therapeutics's earnings has grown year over year. Tscan Therapeutics's earnings in the past year totalled -$89.22 million.

What is TCRX's earnings date?

Tscan Therapeutics's earnings date is Invalid Date. Add TCRX to your watchlist to be reminded of TCRX's next earnings announcement.

What was TCRX's revenue last quarter?

On Invalid Date, Tscan Therapeutics (NASDAQ: TCRX) reported Q4 2023 revenue of $7.21 million up 132.99% year over year. In the same quarter last year, Tscan Therapeutics's revenue was $3.10 million.

What was TCRX's revenue growth in the past year?

As of Q2 2024, Tscan Therapeutics's revenue has grown 55.52% year over year. This is 92.89 percentage points lower than the US Biotechnology industry revenue growth rate of 148.4%. Tscan Therapeutics's revenue in the past year totalled $21.05 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.